SCHEMBL16360

SCHEMBL16360

CC(O)(c1ccc(N2CCN(S(=O)(=O)C3=CC=CCC3=S)C[C@@H]2COCc2cccnc2)cc1)C(F)(F)F

nearest known ligand 0.44

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
GCK P35557 10/20 0.44
GCKR Q14397 9/20 0.42
HSD11B1 P28845 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12078722 1.00 GCK (0.44) GCKGCKRHSD11B1
SCHEMBL12078299 1.00 GCK (0.44) GCKGCKRHSD11B1
SCHEMBL16139 1.00 GCK (0.44) GCKGCKRHSD11B1
SCHEMBL12079076 1.00 GCK (0.44) GCKGCKRHSD11B1
SCHEMBL17394 1.00 GCK (0.44) GCKGCKRHSD11B1
SCHEMBL12078676 1.00 GCK (0.44) GCKGCKRHSD11B1
SCHEMBL16928 0.91 GCKR (0.46) GCKGCKR
SCHEMBL17000 0.91 GCKR (0.46) GCKGCKR
SCHEMBL16966 0.91 GCKR (0.46) GCKGCKR
SCHEMBL16895 0.91 GCKR (0.46) GCKGCKR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2609081-A1 SULFONYLPIPERAZINE DERIVATIVES THAT INTERACT WITH GLUCOKINASE REGULATORY PROTEIN FOR THE TREATMENT OF DIABETES Amgen Inc. (US) 2013-07-03 EP disclosed
WO-2012027261-A1 SULFONYLPIPERAZINE DERIVATIVES THAT INTERACT WITH GLUCOKINASE REGULATORY PROTEIN FOR THE TREATMENT OF DIABETES AMGEN INC. (US) 2012-03-01 WO disclosed